FDA inspection
Lucasti Christopher, D.O.: FDA inspection ending Jan 25, 2019
FDA inspection 1079073 · No Action Indicated (NAI) · Somers Point, NJ
Key facts
| Inspection ID | 1079073 |
|---|---|
| Firm | Lucasti Christopher, D.O. |
| FEI number | 3003249248 |
| Address | 730 Shore Rd |
| City | Somers Point |
| State | NJ |
| ZIP | 08244 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Jan 25, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data